drugset

drugset / Trial / NCT00263705

Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II Study

NCT00263705 ↗

Phase 2 Completed 43 enrolled Jules Bordet Institute

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Determination of guidelines regarding the use of adjuvant chemotherapy for early breast cancer in this population of Patients over 70 years old.

Timeline

Start: 2003-01
Primary completion: 2009-08
Completion: 2009-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Capecitabine	Small molecule	1000 mg/m2	—

Indications